{"id":17070,"date":"2014-08-13T09:54:11","date_gmt":"2014-08-13T07:54:11","guid":{"rendered":"http:\/\/ibecbarcelona.eu\/?page_id=17070"},"modified":"2026-01-16T15:02:10","modified_gmt":"2026-01-16T14:02:10","slug":"bacterial-infections-antimicrobial-therapies","status":"publish","type":"page","link":"https:\/\/ibecbarcelona.eu\/es\/bactinf","title":{"rendered":"Bacterial infections: antimicrobial therapies"},"content":{"rendered":"
\n

About<\/h2>\n
\n\n\n\n\n

The Bacterial infections: antimicrobial therapies group is a senior group.<\/em><\/p>\n\n\n\n

Infectious diseases constitute a tenacious and major public health problem all over the world. The emergence and increasing prevalence of bacterial strains that are resistant to available antibiotics demand the discovery of new therapeutic approaches. <\/h4>\n\n\n\n
\n

Biofilms are bacterial communities that grow embedded within a protective matrix produced by themselves.<\/p>\n<\/blockquote>\n\n\n\n

Chronic infections caused by bacteria growing in biofilms, are enormously complicated to treat. It increases their fitness and survival, thus complicating treatment and diagnosis because they persist despite the action of antibiotic therapies and adaptive immune responses.<\/p>\n\n\n\n

Over 60% of all human infections are characterized by the formation of a biofilm, which is involved in a wide variety of pathological conditions by either growing over human tissues (Cystic Fibrosis, Chronic Obstructive Pulmonary Disease, chronic wound, etc.) or by developing on the surfaces of medical devices (e.g. endotracheal tubes, intravenous and urinary catheters, etc.).<\/p>\n\n\n\n

Our lab aims to investigate new antimicrobial therapies and strategies to combat bacterial infections with different objectives:<\/p>\n\n\n\n